BEFINRA

Eli Lilly and Company

Application Filed: 2013-12-17
Trademark Application Details
Trademark Logo BEFINRA

Mark For: BEFINRA™ trademark registration is intended to cover the categories of pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases.

Status

2021-07-25 UTC
DEAD APPLICATION Refused Dismissed or Invalidated
This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.


Website www.lilly.com whois domain owner info
Research OneLook Acronym Finder
Serial Number86145900
Mark Literal ElementsBEFINRA
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTrademark
Current LocationINTENT TO USE SECTION 2015-01-27
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Domestic RepresentativeBruce W. Longbottom
Attorney NameBruce W. Longbottom
Law Office AssignedM30
Employee NameMARTIN, LIEF ANDREW

Timeline

2013-12-17Application Filed
2014-05-27Published
2014-05-27Published for Opposition
2015-01-27Location: INTENT TO USE SECTION
2017-08-28Abandon
2017-08-28Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume
2017-08-28Status: Dead/Abandoned
2018-07-08Transaction Date

Trademark Parties (Applicants & Owners)

Party: Eli Lilly and Company
AddressLilly Corporate Center Indianapolis, INDIANA UNITED STATES 46285
Legal Entity TypeCorporation
Legal Entity StateINDIANA

Attorney of Record

Bruce W. Longbottom
Eli Lilly and Company
Lilly Corporate Center
Indianapolis IN 46285

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases

Trademark Filing History

DescriptionDateProceeding Number
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED2017-08-28
ABANDONMENT - NO USE STATEMENT FILED2017-08-2899999
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2017-03-09
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2017-03-09
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2016-12-20
EXTENSION 5 GRANTED2016-12-1869302
TEAS EXTENSION RECEIVED2016-12-13
EXTENSION 5 FILED2016-12-1369302
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2016-07-13
EXTENSION 4 GRANTED2016-07-1269302
TEAS EXTENSION RECEIVED2016-06-28
EXTENSION 4 FILED2016-06-2869302
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2015-10-02
EXTENSION 3 GRANTED2015-10-0169302
TEAS EXTENSION RECEIVED2015-09-29
EXTENSION 3 FILED2015-09-2969302
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2015-07-03
EXTENSION 2 GRANTED2015-07-0269302
TEAS EXTENSION RECEIVED2015-06-25
EXTENSION 2 FILED2015-06-2569302
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2015-01-28
EXTENSION 1 GRANTED2015-01-2769302
CASE ASSIGNED TO INTENT TO USE PARALEGAL2015-01-2769302
TEAS EXTENSION RECEIVED2014-12-08
EXTENSION 1 FILED2014-12-0869302
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2014-07-22
PUBLISHED FOR OPPOSITION2014-05-27
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2014-05-27
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2014-05-07
LAW OFFICE PUBLICATION REVIEW COMPLETED2014-04-2268123
ASSIGNED TO LIE2014-04-1768123
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2014-03-256328
EXAMINERS AMENDMENT E-MAILED2014-03-256328
EXAMINERS AMENDMENT -WRITTEN2014-03-2585328
EXAMINER'S AMENDMENT ENTERED2014-03-2588888
ASSIGNED TO EXAMINER2014-03-2585328
APPROVED FOR PUB - PRINCIPAL REGISTER2014-03-25
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2014-01-02
NEW APPLICATION ENTERED IN TRAM2013-12-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed